The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes

Mol Brain. 2016 Dec 16;9(1):99. doi: 10.1186/s13041-016-0280-9.

Abstract

Apurinic/apyrimidinic endonuclease 1 (APE1), a ubiquitous multipurpose protein, is also known as redox effector factor-1 (Ref-1). It is involved in DNA repair and redox signaling and, in turn, oxidative stress-induced neurodegeneration. Although previous studies have demonstrated that APE1/Ref-1 functions as a negative regulator of inflammatory response via several mechanisms in neuronal cells, little is known about the roles of APE1/Ref-1 in glial cells. In this study, we found that cytoplasmic APE1/Ref-1 expression was upregulated in reactive astrocytes of the kainic acid- or lipopolysaccharide (LPS)-injected hippocampus. Analysis of the inflammatory response induced by extranuclear APE1/Ref-1 (ΔNLS-Ref-1) in cultured primary astrocytes revealed that it markedly suppressed inducible nitric oxide synthase (iNOS) expression and tumor necrosis factor-α (TNF-α) secretion induced by LPS to a similar extent as did wild type APE1/Ref-1 (WT-Ref-1), supporting the concept an anti-inflammatory role of extranuclear APE1/Ref-1 in astrocytes. Additionally, overexpression of WT- and ΔNLS-Ref-1 suppressed the transcriptional activity of nuclear factor-κB (NF-κB), although it effectively enhanced activator protein 1 (AP-1) activity. The blunting effect of APE1/Ref-1 on LPS-induced NF-κB activation was not mediated by IκB kinase (IKK) activity. Instead, APE1/Ref-1 inhibited p300-mediated acetylation of p65 by suppressing intracellular reactive oxygen species (ROS) levels following LPS treatment. Taken together, our results showed that altered expression and/or subcellular distribution of APE1/Ref-1 in activated astrocytes regulated the neuroinflammatory response to excitotoxin and endotoxin insults used in model of neurodegenerative brain diseases.

Keywords: APE1/Ref-1; Astrocytes; Inflammation; TNF-α; iNOS.

MeSH terms

  • Acetylation
  • Animals
  • Anti-Inflammatory Agents / metabolism*
  • Astrocytes / metabolism*
  • Cells, Cultured
  • Cytoplasm / enzymology
  • DNA-(Apurinic or Apyrimidinic Site) Lyase / metabolism*
  • E1A-Associated p300 Protein / metabolism
  • Hippocampus / pathology
  • Humans
  • I-kappa B Kinase / metabolism
  • Inflammation / pathology
  • Kainic Acid
  • Lipopolysaccharides
  • Nitric Oxide Synthase Type II / metabolism
  • Protein Transport
  • Rats
  • Reactive Oxygen Species / metabolism
  • Sequence Deletion
  • Signal Transduction
  • Subcellular Fractions / metabolism
  • Transcription Factor RelA / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • Reactive Oxygen Species
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type II
  • E1A-Associated p300 Protein
  • Ep300 protein, rat
  • I-kappa B Kinase
  • Apex1 protein, rat
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Kainic Acid